tiprankstipranks
Beam Therapeutics (MX:BEAM)
:BEAM
Mexico Market
BEAM
Beam Therapeutics
RESEARCH TOOLSreports

Beam Therapeutics (BEAM) Income Statement

0 Followers

Beam Therapeutics Income Statement

Last quarter (Q2 2026), Beam Therapeutics's total revenue was $490.00K, a decrease of -94.21% from the same quarter last year. In Q2, Beam Therapeutics's net income was $-122.68M. See Beam Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 139.74M$ 63.52M$ 377.71M$ 60.92M$ 51.84M
Gross Profit
$ 117.45M$ -304.04M$ 377.71M$ -250.67M$ -180.29M
Operating Expenses
$ 501.14M$ 111.53M$ 554.19M$ 87.81M$ 212.18M
Depreciation and Amortization
$ 6.34M$ 21.93M$ 29.53M$ 14.15M$ 7.45M
EBITDA
$ -29.92M$ -354.78M$ -101.63M$ -271.53M$ -230.06M
Operating Income
$ -383.69M$ -415.57M$ -176.49M$ -338.48M$ -392.46M
Other Income/Expenses
$ 303.70M$ 38.87M$ 45.32M$ 52.80M$ 21.83M
Pretax Income
$ -79.99M$ -376.70M$ -131.16M$ -285.68M$ -370.64M
Net Income
$ -79.99M$ -376.74M$ -132.53M$ -289.09M$ -370.64M
Per Share Metrics
Basic EPS
$ -0.81$ -4.58$ -1.72$ -4.13$ -5.77
Diluted EPS
$ -0.81$ -4.58$ -1.72$ -4.13$ -5.77
Weighted Average Shares Outstanding
 98.91M 82.31M 77.15M 70.02M 64.23M
Weighted Average Shares Outstanding (Diluted)
 98.91M 82.31M 77.15M 70.02M 64.23M
Currency in USD

Beam Therapeutics Earnings and Revenue History